About Respiri
Respiri Limited (ASX:RSH, OTCQB:RSHUF)

Respiri is an Australian e-Health SaaS company supporting respiratory health management focusing primarily on supporting the US healthcare market. Respiri is listed on the Australian Securities Exchange (ASX) and trades on the OTCQB under the ticker “RSHUF” for North American based investors.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam varius neque risus, nec pellentesque leo pharetra a. Nam consequat, felis at euismod commodo, elit ex malesuada elit, et bibendum ipsum justo vel leo. Praesent hendrerit lorem vel risus lacinia, et dictum diam dictum.

The Executive team

Respiri boasts a world class team consisting of a highly respected Chief Executive Office with a career spanning the healthcare industry, providing valuable experience in medical devices, pharmaceuticals, information systems, technology and sleep disorder solutions. A General Manager of Commercial Operations leading the Commercialisation Team bringing extensive experience in health, successful launches and building teams. An experienced Chief Clinical Officer leading Respiri’s algorithm development and clinical content, and a Chief Technical Officer, with Silicon Valley pedigree, leading the build of the app and data management infrastructure.

The entire team is the driving force behind the new SaaS strategy.

The Board
Nicholas Smedley
Executive Chairman
Mr Smedley is an experienced Investment Banker and M&A Advisor, with 14 years’ experience at UBS and KPMG. He has worked on M&A transactions in the UK, Hong Kong, China, and Australia with transactions ranging from the A$9bn defence of WMC Resources through to the investment of $65m into Catch.com.au. Nicholas currently oversees investments in the Property, Aged care, Technology and Medical Technology space. Key areas of expertise include M&A, Debt structuring, Corporate governance and innovation. He holds a Bachelor of Commerce from Monash University.
Nicholas-Smedley
Marjan Mikel
Chief Executive Officer

Marjan has been at the helm of Respiri taking it from R&D to commercialisation since 2020. A highly experienced managing director and board member with a career spanning Australia, Europe and Japan, Marjan’s focus has been in the healthcare industry; from pharmaceuticals and information services and technology to medical devices and sleep disorder solutions. He founded and subsequently sold Healthy Sleep Solutions after developing it into a successful business, with ResMed Ltd as a joint venture/shareholder partner.

Currently, Marjan also acts as commercial advisor to Portt, a SaaS company, and is an industry research fellow at University of New South Wales Faculty of Engineering.

Qualifications: BSc (Hons), University of Sydney, Grad Dip Ed, Secondary Education, University of Sydney, MCom Masters of Commerce, University of New South Wales, MAICD, Business Administration, Management and Operations, AGSM, University of New South Wales

https://www.linkedin.com/in/marjan-mikel-74aa784/

Marjan-Mikel
Andrew Metcalfe
Company Secretary
Andrew Metcalfe (CPA, FGIA, GAICD) is an experienced Chartered Secretary and Governance Adviser with more than 25 years’ experience across a broad industry base, having worked with a variety of Board and senior management teams of ASX listed companies.
Andrew-Metcalfe

You are about to leave this website.

Respiri LTD is not responsible for the content or policies on the linked website.

Do you wish to continue?